EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Management of Apnoea in Extremely Preterm Infants: A European Survey

Anna Lavizzari, G Jeroen Hutten, Christian Heiring, Moniek van de Loo, Wes Onland, Almudena Alonso-Ojembarrena, Harald Ehrhardt, Merih Cetinkaya, Tomasz Szczapa, Victor Sartorius, Gustavo Rocha, Martin Wald und 20 weitere

Neonatology · 2025

DOI: 10.1159/000547546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neonatology, 2025. Verfasst von Anna Lavizzari und 31 weiteren Autor:innen. Beteiligte Einrichtung: Neonatal Intensive Care Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy. Hauptthemen laut MEDLINE: Apnea, Caffeine, Infant, Extremely Premature, Practice Patterns, Physicians'. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Episodes of apnoea are common in extremely preterm infants (EPIs) and usually treated with caffeine and respiratory support. Understanding differences in apnoea definitions, monitoring practices, and use of respiratory stimulants is essential to improve future treatment.

Methods

Between March and July 2024, one lead consultant at European tertiary neonatal intensive care units (NICUs) was invited to complete a web-based survey on respiratory practices in EPIs. We sought information how they defined apnoea and monitored for it, and how they treated it with caffeine, doxapram, and non-invasive respiratory support.

Results

We received replies from 447/721 (62%) NICUs across 24 European countries. Most NICUs (74%) use both electrocardiogram electrodes and pulse oximetry for apnoea monitoring. All NICUs reported using caffeine citrate, with 102 centres (23%) starting it in the delivery room. The median loading, maintenance and maximum maintenance doses used are 20 mg/kg, 5 and 10 mg/kg/day, respectively. Caffeine is occasionally given twice daily in some NICUs (30%) and stopped at 34–35 weeks of postmenstrual age at most of them (74%). Doxapram is used at 111 (25%) NICUs, with geographical differences. Strategies for the use and escalation of non-invasive respiratory support in case of persistent apnoea are not clearly defined. Automatic closed-loop oxygen delivery is used at 25% of NICUs.

Conclusion

Despite consistency in the dosing and weaning of caffeine, there is much variation in the management of apnoea in preterm infants across Europe. Future research should focus on timing and dosage of caffeine, the use of doxapram, and strategies for optimising non-invasive respiratory support.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApneaCaffeineInfant, Extremely PrematurePractice Patterns, Physicians'HumansInfant, NewbornEuropeIntensive Care Units, NeonatalDoxapramSurveys and QuestionnairesCitratesNoninvasive VentilationOximetryHealth Care Surveys

Stichwörter der Autor:innen

ApnoeaCaffeineDoxapramEuropean surveyInfantPreterm infants

Substanzen

CaffeineDoxapramcaffeine citrateCitrates

Autor:innen und Institutionen

  • Neonatal Intensive Care Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Neonatology, Emma Children's Hospital, Amsterdam UMC, Amsterdam, The Netherlands.
  • Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Neonatal and Pediatric Intensive Care, Copenhagen University Hospital, Copenhagen, Denmark.
  • Neonatal Intensive Care Unit, Hospital Universitario Puerta del Mar, Cadiz, Spain.
  • Research Unit, Puerta del Mar University Hospital, Biomedical Research and Innovation Institute of Cádiz (INiBICA), Cadiz, Spain.

Zitieren

APA

Lavizzari, A., Hutten, G. J., Heiring, C., van de Loo, M., Onland, W., Alonso-Ojembarrena, A., Ehrhardt, H., Cetinkaya, M., Szczapa, T., Sartorius, V., Rocha, G., Wald, M., Soukka, H., Danhaive, O., Dassios, T., Cucerea, M. C., Calkovska, A., Dimitriou, G., Barzilay, B., …, & ESPR Pulmonary Research Consortium (2025). Management of Apnoea in Extremely Preterm Infants: A European Survey. Neonatology. https://doi.org/10.1159/000547546

Vancouver

Lavizzari A, Hutten GJ, Heiring C, van de Loo M, Onland W, Alonso-Ojembarrena A, et al. Management of Apnoea in Extremely Preterm Infants: A European Survey. Neonatology. 2025. doi:10.1159/000547546

BibTeX
@article{Lavizzari2025,
  author = {Lavizzari, Anna and Hutten, G Jeroen and Heiring, Christian and van de Loo, Moniek and Onland, Wes and Alonso-Ojembarrena, Almudena and Ehrhardt, Harald and Cetinkaya, Merih and Szczapa, Tomasz and Sartorius, Victor and Rocha, Gustavo and Wald, Martin and Soukka, Hanna and Danhaive, Olivier and Dassios, Theodore and Cucerea, Manuela Camelia and Calkovska, Andrea and Dimitriou, Gabriel and Barzilay, Bernard and Filipovic-Grcic, Boris and Hentschel, Roland and Thome, Ulrich H and Bohlin, Kajsa and Lista, Gianluca and Schulzke, Sven and Plavka, Richard and Tameliene, Rasa and O'Donnell, Colm Patrick Finbarr and van Kaam, Anton H and Sindelar, Richard and Klingenberg, Claus and ESPR Pulmonary Research Consortium, ESPR Pulmonary Research Consortium},
  title = {Management of Apnoea in Extremely Preterm Infants: A European Survey},
  journal = {Neonatology},
  year = {2025},
  doi = {10.1159/000547546}
}
Kostenlos starten →